CN107056950A - 一种包含钥孔血蓝蛋白片段的融合蛋白及其应用 - Google Patents

一种包含钥孔血蓝蛋白片段的融合蛋白及其应用 Download PDF

Info

Publication number
CN107056950A
CN107056950A CN201710183230.XA CN201710183230A CN107056950A CN 107056950 A CN107056950 A CN 107056950A CN 201710183230 A CN201710183230 A CN 201710183230A CN 107056950 A CN107056950 A CN 107056950A
Authority
CN
China
Prior art keywords
leu
ala
phe
asp
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710183230.XA
Other languages
English (en)
Other versions
CN107056950B (zh
Inventor
陈春光
崔玲玲
刘燕云
向艳文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
You (shanghai) Biotechnology Co Ltd
Original Assignee
You (shanghai) Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by You (shanghai) Biotechnology Co Ltd filed Critical You (shanghai) Biotechnology Co Ltd
Priority to CN201710183230.XA priority Critical patent/CN107056950B/zh
Publication of CN107056950A publication Critical patent/CN107056950A/zh
Application granted granted Critical
Publication of CN107056950B publication Critical patent/CN107056950B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明公开了一种包含钥孔血蓝蛋白片段的融合蛋白及其应用。所述融合蛋白包含钥孔血蓝蛋白片段及目的蛋白;所述的钥孔血蓝蛋白片段包含钥孔血蓝蛋白第1‑245位氨基酸残基;所述的目的蛋白为植物线粒体膜蛋白或其免疫原性片段。在将钥孔血蓝蛋白片段与目的蛋白融合表达后,钥孔血蓝蛋白片段显著增强了目的蛋白的免疫原性。由于本发明的融合蛋白展示了比单独的目的蛋白更强的免疫原性,因此,通过融合钥孔血蓝蛋白片段可用于制备针对特异性目的蛋白多克隆抗体。

Description

一种包含钥孔血蓝蛋白片段的融合蛋白及其应用
技术领域
本发明涉及生物技术领域,具体涉及一种包含钥孔血蓝蛋白片段的融合蛋白及其应用。
背景技术
抗体是高等动物特异性免疫应答反应所产生的免疫球蛋白,负责特异抗原的识别和清除。抗体不仅是机体抵抗病原体入侵的强大武器,也是基础科学研究中用于特异性分子识别的重要工具。随着基因组学研究深入,人们更加认识到基因组学研究的成果必须在蛋白水平得到进一步的研究和验证。
一直以来,基于亲和(affinity)相互作用的研究手段是研究蛋白质功能的主要手段之一,而基于抗体-抗原亲和相互作用研究手段又是其中最主要的应用方法,在科研与生产应用中有多种衍生技术应用,包括ELISA、免疫印记、免疫荧光、抗体芯片等。因此,制备高质量的抗体成为人们在科研、诊断以及治疗领域中一项核心技术。
在抗体制备过程中,一般都用人工合成的多肽或者细菌表达的重组蛋白质作为抗原。人工合成多肽首先需对该蛋白含有的表位信息进行准确预测,由于合成的片段较短,因此还需要选择合适的免疫原性载体蛋白偶联以形成免疫原,否则用多肽刺激动物产生的抗体对相应的天然蛋白质抗原亲和力低或完全不能识别。而用细菌表达的重组蛋白质经常会遇到一些蛋白难以表达等情况。另外,有些蛋白质免疫原性较低,很难在机体刺激产生特异性抗体。因此,在制备针对各种不同的蛋白质特异性抗体时,首先需要在对抗原制备技术进行革新。
研究发现,将特异性抗原蛋白与某一免疫原性增强蛋白构建成融合蛋白,可明显促进免疫动物对特异性靶蛋白的免疫应答。如Suzue等发现结核分枝杆菌hsp70可加强小鼠对于与之相连的蛋白产生特异性的抗体或细胞免疫应答(Suzue,K.&Young,R.A.:J.Immunol.156:873-9,1996)。专利CN201310437663公开结核分枝杆菌细胞色素C氧化酶亚基Ⅱ蛋白和特异性抗原蛋白组成融合蛋白能显著增强后者的免疫原性。专利CN201210181392公开白喉毒素无毒突变体CRM197或其片段在融合蛋白中作为分子内佐剂增强与其融合的目的蛋白的免疫原性。
钥孔血蓝蛋白(keyhole limpet hemocyanin,KLH)广泛作为载体蛋白交联于半抗原和其他抗原,使它们具有更强的免疫原性以用于抗体的制备。但钥孔血蓝蛋白的氨基酸序列较长,其中的哪个片段与其他抗原连接能够显著增加免疫原性,迄今为止现有技术从未报道过。
发明内容
本发明的目的在于提供一种包含钥孔血蓝蛋白片段的融合蛋白,用以增强与之融合的目的蛋白的免疫原性。
为实现上述目的,本发明通过以下方案予以实现:
一种融合蛋白,包含钥孔血蓝蛋白片段(sKLH片段)及目的蛋白。
优选地,所述的钥孔血蓝蛋白片段包含钥孔血蓝蛋白第1-245位氨基酸残基。
优选地,所述的钥孔血蓝蛋白片段包含SEQ ID NO:1所示的第1-245位氨基酸残基。
我们对KLH蛋白序列研究发现,该蛋白N端含有多段T-细胞和B-细胞表位。动物实验表明,上述融合蛋白sKHL片段能有效刺激针对与之相连蛋白的特异性免疫应答。
优选地,所述的目的蛋白为植物线粒体膜蛋白(NAD4)或其免疫原性片段。
优选地,所述的目的蛋白的序列如SEQ ID NO:5所示。
优选地,所述的钥孔血蓝蛋白片段连接至所述目的蛋白的N端和/或C端。
在本发明中,将两种或更多种蛋白融合表达以形成融合蛋白的技术是本领域公知的(参见例如,J.Sambrook等人,分子克隆:实验室手册,第2版,冷泉港实验室出版社,1989)。通常,通过使用重组DNA技术将编码两种或更多种蛋白的DNA片段符合读框地连接在一起,并进行蛋白质表达来获得融合蛋白。
一种编码上述的融合蛋白的核苷酸。
优选地,所述的核苷酸,包含SEQ ID NO:3所述的核苷酸序列。
一种上述融合蛋白在制备针对特异性目的蛋白多克隆抗体中的应用。
一种上述融合蛋白在作为疫苗或药物的应用。
本发明方法具有如下优点:在将sKLH片段与目的蛋白融合表达后,sKLH片段显著增强了目的蛋白的免疫原性。实施例试验数据证明,sKLH片段与目的蛋白NAD4融合后,其作为抗原免疫获得的多克隆抗体特异性显著优于单独使用NAD4蛋白制备的抗体。由于本发明的融合蛋白展示了比单独的目的蛋白更强的免疫原性,因此,通过融合sKLH片段可用于制备针对特异性目的蛋白多克隆抗体。
附图说明
图1为sKLH片段表达载体pE-sKLH质粒图。
图2为NAD4蛋白表达载体pE-NAD4质粒图。
图3为融合蛋白表达载体pE-sKLH-NAD4质粒图。
图4为NAD4蛋白表达、纯化SDS-PAGE图。
图5为sKLH-NAD4融合蛋白表达、纯化SDS-PAGE图。
图6为Western blot鉴定兔抗血清质量效果图。
具体实施方式
以下实施例用于说明本发明,但不用来限制本发明的范围。
实施例1 sKLH片段基因合成及NAD4基因克隆
sKLH片段基因合成根据GenBank数据库中钥孔血蓝蛋白蛋白基因编码序列(Accession Number:AJ698341.2,其核苷酸序列如SEQ ID NO:2所示),同时依据E.coli遗传密码偏好性将sKLH片段(1-245位氨基酸)基因序列进行了密码子优化,由南京金斯瑞生物科技有限公司合成并构建pUC57-sKLH质粒,经密码子优化并加入酶切位点后的核酸序列如SEQ ID NO:3所示。
NAD4基因克隆拟南芥叶片组织经液氮研磨并经Trizol(Invitrogen)提取获得RNA,再经III反转录酶处理获得cDNA。以cDNA为模板,高保真PCR获得NAD4基因核苷酸序列(如SEQ ID NO:4所示)。扩增引物设计如表1所示:
表1.NAD4基因扩增引物表
SEQ ID NO: 引物名称 引物序列(5’-3’)
6 NAD4_EcoRI_F TCCGAATTCGGTGTTTTATATGACC
7 NAD4_HindIII_R GCAAGCTTATGAAATTTGCCATGTTG
实施例2蛋白表达载体pE-sKLH-NAD4质粒的构建
pE-sKLH质粒的构建质粒pUC57-sKLH(实施例1制备得到)经NcoI和BamHI双酶切(NEB),胶回收酶切含sKLH片段基因(~740bp),与同样经NcoI和BamHI双酶切胶回收后的pET-28a质粒连接,转化DH5α感受态细菌,卡拉霉素抗性平板筛选阳性克隆,T7引物测序鉴定pE-sKLH质粒。
pE-NAD4质粒的构建高保真PCR获得的NAD4基因核苷酸序列(实施例1制备得到)经EcoRI和HindIII双酶切(NEB),胶回收酶切含NAD4核酸片段(~430bp),与同样经EcoRI和HindIII双酶切胶回收后的pET-28a质粒连接,转化DH5α感受态细菌,卡拉霉素抗性平板筛选阳性克隆,T7引物测序鉴定pE-NAD4质粒。
pE-sKLH-NAD4质粒的构建质粒pE-NAD4经EcoRI和HindIII双酶切(NEB),胶回收酶切含NAD4核酸片段(~430bp),与同样经EcoRI和HindIII双酶切胶回收后的pE-sKLH质粒连接,转化DH5α感受态细菌,卡拉霉素抗性平板筛选阳性克隆,T7引物测序鉴定pE-sKLH-NAD4质粒。
实施例3 sKLH-NAD4融合蛋白表达及纯化
从含卡那霉素LB平板上挑取含有pE-NAD4及pE-sKLH-NAD4质粒的单菌落,分别接种于10ml含卡那霉素的液体LB培养基中,在37℃180rpm下振荡培养过夜,取5ml再转接到500mL含卡那霉素的LB培养液中,在37℃180rpm下振荡培养4-5小时。当OD600达0.6左右时,加入IPTG至终浓度0.5mM,在37℃下振荡诱导4个小时。诱导后,以8000g离心10min收集菌体,然后按1g菌体对应20ml裂解液(20mM Tris-HCl,pH7.6,300mM NaCl,5mM EDTA)悬浮,高压均质破碎2次,600bar。12000g离心30min,弃上清保留沉淀(即包涵体)。再用重悬液(20mMTris-HCl pH8.0,300mM NaCl)重悬沉淀,高压均质破碎1次,600bar。离心弃上清,沉淀用含8M尿素上样缓冲液(20mM NaPO3,pH8.0,300mM NaCl,8M urea)重悬,20000g离心30min后,取上清进行Ni-NTI(qiagen)亲和层析。NAD4蛋白及sKLH-NAD4融合蛋白的表达、纯化情况如图5所示。
实施例4兔多克隆抗血清的制备
用纯化的抗原NAD4蛋白及sKLH-NAD4融合蛋白分别对4月龄的健康新西兰大白兔进行免疫,初免剂量为0.3mg/只,二免、三免剂量为0.2mg/只。初免抗原为蛋白抗原与等体积弗氏完全佐剂混匀乳化,二免、三免、抗原蛋白与等体积弗氏不完全佐剂混匀乳化。每次免疫间隔时间为2周,三免2周后取采血,3000g离心15分钟后得到抗血清。弗氏完全佐剂与弗氏不完全佐剂均购自Sigma。
实施例5 Western blot鉴定兔抗血清质量
拟南芥叶片蛋白裂解提取后,进行SDS-PAGE电泳分离,并转移到PVDF膜上,用于Western blot鉴定。PVDF膜用含5%脱脂牛奶TBST溶液(50mM Tris-HCl,pH7.6,150mMNaCl,0.05%Tween-20)封闭1h,然后加入按1:2500稀释,反应1h;用TBST溶液洗膜3次,每次15min;然后加入羊抗兔lgG偶联(辣根过氧化物酶)二抗孵育1h;继续用TBST溶液洗膜3次,每次15min;然后加入ECL反应液至膜上反应2min,胶片曝光10s-5min。分别用sKLH-NAD4融合蛋白和NAD4蛋白免疫得到的多克隆抗体进行的Western blot检测结果示于图6。结果显示,使用融合蛋白sKLH-NAD融合蛋白作为抗原免疫获得的多克隆抗体特异性显著优于单独使用NAD4蛋白制备的抗体。
虽然,上文中已经用一般性说明及具体实施例对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
SEQUENCE LISTING
<110> 攸归(上海)生物科技有限公司
<120> 一种包含钥孔血蓝蛋白片段的融合蛋白及其应用
<130>
<160> 7
<170> PatentIn version 3.5
<210> 1
<211> 3408
<212> PRT
<213> 钥孔血蓝蛋白(KLH,keyhole limpet hemocyanin)
<400> 1
Met Leu Ser Val Arg Leu Leu Ile Val Val Leu Ala Leu Ala Asn Ala
1 5 10 15
Glu Asn Leu Val Arg Lys Ser Val Glu His Leu Thr Gln Glu Glu Thr
20 25 30
Leu Asp Leu Gln Ala Ala Leu Arg Glu Leu Gln Met Asp Ser Ser Ser
35 40 45
Ile Gly Phe Gln Lys Ile Ala Ala Ala His Gly Ala Pro Ala Ser Cys
50 55 60
Val His Lys Asp Thr Ser Ile Ala Cys Cys Ile His Gly Met Pro Thr
65 70 75 80
Phe Pro His Trp His Arg Ala Tyr Val Val His Met Glu Arg Ala Leu
85 90 95
Gln Thr Lys Arg Arg Thr Ser Gly Leu Pro Tyr Trp Asp Trp Thr Glu
100 105 110
Pro Ile Thr Gln Leu Pro Ser Leu Ala Ala Asp Pro Val Tyr Ile Asp
115 120 125
Ser Gln Gly Gly Lys Ala His Thr Asn Tyr Trp Tyr Arg Gly Asn Ile
130 135 140
Asp Phe Leu Asp Lys Lys Thr Asn Arg Ala Val Asp Asp Arg Leu Phe
145 150 155 160
Glu Lys Val Lys Pro Gly Gln His Thr His Leu Met Glu Ser Val Leu
165 170 175
Asp Ala Leu Glu Gln Asp Glu Phe Cys Lys Phe Glu Ile Gln Phe Glu
180 185 190
Leu Ala His Asn Ala Ile His Tyr Leu Val Gly Gly Lys His Asp Tyr
195 200 205
Ser Met Ala Asn Leu Glu Tyr Thr Ala Tyr Asp Pro Ile Phe Phe Leu
210 215 220
His His Ser Asn Val Asp Arg Ile Phe Ala Ile Trp Gln Arg Leu Gln
225 230 235 240
Glu Leu Arg Asn Lys Asp Pro Lys Ala Met Asp Cys Ala Gln Glu Leu
245 250 255
Leu His Gln Lys Met Glu Pro Phe Ser Trp Glu Asp Asn Asp Ile Pro
260 265 270
Leu Thr Asn Asp Tyr Asp Thr Leu Asn Leu Asn Gly Met Thr Pro Glu
275 280 285
Glu Leu Lys Thr Tyr Leu Asp Glu Arg Ser Ser Arg Ala Arg Ala Phe
290 295 300
Ala Ser Phe Arg Leu Lys Gly Phe Gly Gly Ser Ala Asn Val Phe Val
305 310 315 320
Tyr Val Cys Ile Pro Asp Asp Asn Asp Arg Asn Asp Asp His Cys Glu
325 330 335
Lys Ala Gly Asp Phe Phe Val Leu Gly Gly Pro Ser Glu Met Lys Trp
340 345 350
Gln Phe Tyr Arg Pro Tyr Leu Phe Asp Leu Ser Asp Thr Val His Lys
355 360 365
Met Gly Met Lys Leu Asp Gly His Tyr Thr Val Lys Ala Glu Leu Phe
370 375 380
Ser Val Asn Gly Thr Ala Leu Pro Asp Asp Leu Leu Pro His Pro Val
385 390 395 400
Val Val His His Pro Glu Lys Gly Phe Thr Asp Pro Pro Val Lys His
405 410 415
His Gln Ser Ala Asn Leu Leu Val Arg Lys Asn Ile Asn Asp Leu Thr
420 425 430
Arg Glu Glu Val Leu Asn Leu Arg Glu Ala Phe His Lys Phe Gln Glu
435 440 445
Asp Arg Ser Val Asp Gly Tyr Gln Ala Thr Ala Glu Tyr His Gly Leu
450 455 460
Pro Ala Arg Cys Pro Arg Pro Asp Ala Lys Asp Arg Tyr Ala Cys Cys
465 470 475 480
Val His Gly Met Pro Ile Phe Pro His Trp His Arg Leu Phe Val Thr
485 490 495
Gln Val Glu Asp Ala Leu Val Gly Arg Gly Ala Thr Ile Gly Ile Pro
500 505 510
Tyr Trp Gly Leu Pro Tyr Trp Asp Trp Thr Glu Pro Met Thr His Ile
515 520 525
Pro Gly Leu Ala Gly Asn Lys Thr Tyr Val Asp Ser His Gly Ala Ser
530 535 540
His Thr Asn Pro Phe His Ser Ser Val Ile Ala Phe Glu Glu Asn Ala
545 550 555 560
Pro His Thr Lys Arg Gln Ile Asp Gln Arg Leu Phe Lys Pro Ala Thr
565 570 575
Phe Gly His His Thr Asp Leu Phe Asn Gln Ile Leu Tyr Ala Phe Glu
580 585 590
Gln Glu Asp Tyr Cys Asp Phe Glu Val Gln Phe Glu Ile Thr His Asn
595 600 605
Thr Ile His Ala Trp Thr Gly Gly Ser Glu His Phe Ser Met Ser Ser
610 615 620
Leu His Tyr Thr Ala Phe Asp Pro Leu Phe Tyr Phe His His Ser Asn
625 630 635 640
Val Asp Arg Leu Trp Ala Val Trp Gln Ala Leu Gln Met Arg Arg His
645 650 655
Lys Pro Tyr Arg Ala His Cys Ala Ile Ser Leu Glu His Met His Leu
660 665 670
Lys Pro Phe Ala Phe Ser Ser Pro Leu Asn Asn Asn Glu Lys Thr His
675 680 685
Ala Asn Ala Met Pro Asn Lys Ile Tyr Asp Tyr Glu Asn Val Leu His
690 695 700
Tyr Thr Tyr Glu Asp Leu Thr Phe Gly Gly Ile Ser Leu Glu Asn Ile
705 710 715 720
Glu Lys Met Ile His Glu Asn Gln Gln Glu Asp Arg Ile Tyr Ala Gly
725 730 735
Phe Leu Leu Ala Gly Ile Arg Thr Ser Ala Asn Val Asp Ile Phe Ile
740 745 750
Lys Thr Thr Asp Ser Val Gln His Lys Ala Gly Thr Phe Ala Val Leu
755 760 765
Gly Gly Ser Lys Glu Met Lys Trp Gly Phe Asp Arg Val Phe Lys Phe
770 775 780
Asp Ile Thr His Val Leu Lys Asp Leu Asp Leu Thr Ala Asp Gly Asp
785 790 795 800
Phe Glu Val Thr Val Asp Ile Thr Glu Val Asp Gly Thr Lys Leu Ala
805 810 815
Ser Ser Leu Ile Pro His Ala Ser Val Ile Arg Glu His Ala Arg Gly
820 825 830
Lys Leu Asn Arg Val Lys Phe Asp Lys Val Pro Arg Ser Arg Leu Ile
835 840 845
Arg Lys Asn Val Asp Arg Leu Ser Pro Glu Glu Met Asn Glu Leu Arg
850 855 860
Lys Ala Leu Ala Leu Leu Lys Glu Asp Lys Ser Ala Gly Gly Phe Gln
865 870 875 880
Gln Leu Gly Ala Phe His Gly Glu Pro Lys Trp Cys Pro Ser Pro Glu
885 890 895
Ala Ser Lys Lys Phe Ala Cys Cys Val His Gly Met Ser Val Phe Pro
900 905 910
His Trp His Arg Leu Leu Thr Val Gln Ser Glu Asn Ala Leu Arg Arg
915 920 925
His Gly Tyr Asp Gly Ala Leu Pro Tyr Trp Asp Trp Thr Ser Pro Leu
930 935 940
Asn His Leu Pro Glu Leu Ala Asp His Glu Lys Tyr Val Asp Pro Glu
945 950 955 960
Asp Gly Val Glu Lys His Asn Pro Trp Phe Asp Gly His Ile Asp Thr
965 970 975
Val Asp Lys Thr Thr Thr Arg Ser Val Gln Asn Lys Leu Phe Glu Gln
980 985 990
Pro Glu Phe Gly His Tyr Thr Ser Ile Ala Lys Gln Val Leu Leu Ala
995 1000 1005
Leu Glu Gln Asp Asn Phe Cys Asp Phe Glu Ile Gln Tyr Glu Ile
1010 1015 1020
Ala His Asn Tyr Ile His Ala Leu Val Gly Gly Ala Gln Pro Tyr
1025 1030 1035
Gly Met Ala Ser Leu Arg Tyr Thr Ala Phe Asp Pro Leu Phe Tyr
1040 1045 1050
Leu His His Ser Asn Thr Asp Arg Ile Trp Ala Ile Trp Gln Ala
1055 1060 1065
Leu Gln Lys Tyr Arg Gly Lys Pro Tyr Asn Val Ala Asn Cys Ala
1070 1075 1080
Val Thr Ser Met Arg Glu Pro Leu Gln Pro Phe Gly Leu Ser Ala
1085 1090 1095
Asn Ile Asn Thr Asp His Val Thr Lys Glu His Ser Val Pro Phe
1100 1105 1110
Asn Val Phe Asp Tyr Lys Thr Asn Phe Asn Tyr Glu Tyr Asp Thr
1115 1120 1125
Leu Glu Phe Asn Gly Leu Ser Ile Ser Gln Leu Asn Lys Lys Leu
1130 1135 1140
Glu Ala Ile Lys Ser Gln Asp Arg Phe Phe Ala Gly Phe Leu Leu
1145 1150 1155
Ser Gly Phe Lys Lys Ser Ser Leu Val Lys Phe Asn Ile Cys Thr
1160 1165 1170
Asp Ser Ser Asn Cys His Pro Ala Gly Glu Phe Tyr Leu Leu Gly
1175 1180 1185
Asp Glu Asn Glu Met Pro Trp Ala Tyr Asp Arg Val Phe Lys Tyr
1190 1195 1200
Asp Ile Thr Glu Lys Leu His Asp Leu Lys Leu His Ala Glu Asp
1205 1210 1215
His Phe Tyr Ile Asp Tyr Glu Val Phe Asp Leu Lys Pro Ala Ser
1220 1225 1230
Leu Gly Lys Asp Leu Phe Lys Gln Pro Ser Val Ile His Glu Pro
1235 1240 1245
Arg Ile Gly His His Glu Gly Glu Val Tyr Gln Ala Glu Val Thr
1250 1255 1260
Ser Ala Asn Arg Ile Arg Lys Asn Ile Glu Asn Leu Ser Leu Gly
1265 1270 1275
Glu Leu Glu Ser Leu Arg Ala Ala Phe Leu Glu Ile Glu Asn Asp
1280 1285 1290
Gly Thr Tyr Glu Ser Ile Ala Lys Phe His Gly Ser Pro Gly Leu
1295 1300 1305
Cys Gln Leu Asn Gly Asn Pro Ile Ser Cys Cys Val His Gly Met
1310 1315 1320
Pro Thr Phe Pro His Trp His Arg Leu Tyr Val Val Val Val Glu
1325 1330 1335
Asn Ala Leu Leu Lys Lys Gly Ser Ser Val Ala Val Pro Tyr Trp
1340 1345 1350
Asp Trp Thr Lys Arg Ile Glu His Leu Pro His Leu Ile Ser Asp
1355 1360 1365
Ala Thr Tyr Tyr Asn Ser Arg Gln His His Tyr Glu Thr Asn Pro
1370 1375 1380
Phe His His Gly Lys Ile Thr His Glu Asn Glu Ile Thr Thr Arg
1385 1390 1395
Asp Pro Lys Asp Ser Leu Phe His Ser Asp Tyr Phe Tyr Glu Gln
1400 1405 1410
Val Leu Tyr Ala Leu Glu Gln Asp Asn Phe Cys Asp Phe Glu Ile
1415 1420 1425
Gln Leu Glu Ile Leu His Asn Ala Leu His Ser Leu Leu Gly Gly
1430 1435 1440
Lys Gly Lys Tyr Ser Met Ser Asn Leu Asp Tyr Ala Ala Phe Asp
1445 1450 1455
Pro Val Phe Phe Leu His His Ala Thr Thr Asp Arg Ile Trp Ala
1460 1465 1470
Ile Trp Gln Asp Leu Gln Arg Phe Arg Lys Arg Pro Tyr Arg Glu
1475 1480 1485
Ala Asn Cys Ala Ile Gln Leu Met His Thr Pro Leu Gln Pro Phe
1490 1495 1500
Asp Lys Ser Asp Asn Asn Asp Glu Ala Thr Lys Thr His Ala Thr
1505 1510 1515
Pro His Asp Gly Phe Glu Tyr Gln Asn Ser Phe Gly Tyr Ala Tyr
1520 1525 1530
Asp Asn Leu Glu Leu Asn His Tyr Ser Ile Pro Gln Leu Asp His
1535 1540 1545
Met Leu Gln Glu Arg Lys Arg His Asp Arg Val Phe Ala Gly Phe
1550 1555 1560
Leu Leu His Asn Ile Gly Thr Ser Ala Asp Gly His Val Phe Val
1565 1570 1575
Cys Leu Pro Thr Gly Glu His Thr Lys Asp Cys Ser His Glu Ala
1580 1585 1590
Gly Met Phe Ser Ile Leu Gly Gly Gln Thr Glu Met Ser Phe Val
1595 1600 1605
Phe Asp Arg Leu Tyr Lys Leu Asp Ile Thr Lys Ala Leu Lys Lys
1610 1615 1620
Asn Gly Val His Leu Gln Gly Asp Phe Asp Leu Glu Ile Glu Ile
1625 1630 1635
Thr Ala Val Asn Gly Ser His Leu Asp Ser His Val Ile His Ser
1640 1645 1650
Pro Thr Ile Leu Phe Glu Ala Gly Thr Asp Ser Ala His Thr Asp
1655 1660 1665
Asp Gly His Thr Glu Pro Val Met Ile Arg Lys Asp Ile Thr Gln
1670 1675 1680
Leu Asp Lys Arg Gln Gln Leu Ser Leu Val Lys Ala Leu Glu Ser
1685 1690 1695
Met Lys Ala Asp His Ser Ser Asp Gly Phe Gln Ala Ile Ala Ser
1700 1705 1710
Phe His Ala Leu Pro Pro Leu Cys Pro Ser Pro Ala Ala Ser Lys
1715 1720 1725
Arg Phe Ala Cys Cys Val His Gly Met Ala Thr Phe Pro Gln Trp
1730 1735 1740
His Arg Leu Tyr Thr Val Gln Phe Gln Asp Ser Leu Arg Lys His
1745 1750 1755
Gly Ala Val Val Gly Leu Pro Tyr Trp Asp Trp Thr Leu Pro Arg
1760 1765 1770
Ser Glu Leu Pro Glu Leu Leu Thr Val Ser Thr Ile His Asp Pro
1775 1780 1785
Glu Thr Gly Arg Asp Ile Pro Asn Pro Phe Ile Gly Ser Lys Ile
1790 1795 1800
Glu Phe Glu Gly Glu Asn Val His Thr Lys Arg Asp Ile Asn Arg
1805 1810 1815
Asp Arg Leu Phe Gln Gly Ser Thr Lys Thr His His Asn Trp Phe
1820 1825 1830
Ile Glu Gln Ala Leu Leu Ala Leu Glu Gln Thr Asn Tyr Cys Asp
1835 1840 1845
Phe Glu Val Gln Phe Glu Ile Met His Asn Gly Val His Thr Trp
1850 1855 1860
Val Gly Gly Lys Glu Pro Tyr Gly Ile Gly His Leu His Tyr Ala
1865 1870 1875
Ser Tyr Asp Pro Leu Phe Tyr Ile His His Ser Gln Thr Asp Arg
1880 1885 1890
Ile Trp Ala Ile Trp Gln Ser Leu Gln Arg Phe Arg Gly Leu Ser
1895 1900 1905
Gly Ser Glu Ala Asn Cys Ala Val Asn Leu Met Lys Thr Pro Leu
1910 1915 1920
Lys Pro Phe Ser Phe Gly Ala Pro Tyr Asn Leu Asn Asp His Thr
1925 1930 1935
His Asp Phe Ser Lys Pro Glu Asp Thr Phe Asp Tyr Gln Lys Phe
1940 1945 1950
Gly Tyr Ile Tyr Asp Thr Leu Glu Phe Ala Gly Trp Ser Ile Arg
1955 1960 1965
Gly Ile Asp His Ile Val Arg Asn Arg Gln Glu His Ser Arg Val
1970 1975 1980
Phe Ala Gly Phe Leu Leu Glu Gly Phe Gly Thr Ser Ala Thr Val
1985 1990 1995
Asp Phe Gln Val Cys Arg Thr Ala Gly Asp Cys Glu Asp Ala Gly
2000 2005 2010
Tyr Phe Thr Val Leu Gly Gly Glu Lys Glu Met Pro Trp Ala Phe
2015 2020 2025
Asp Arg Leu Tyr Lys Tyr Asp Ile Thr Glu Thr Leu Asp Lys Met
2030 2035 2040
Asn Leu Arg His Asp Glu Ile Phe Gln Ile Glu Val Thr Ile Thr
2045 2050 2055
Ser Tyr Asp Gly Thr Val Leu Asp Ser Gly Leu Ile Pro Thr Pro
2060 2065 2070
Ser Ile Ile Tyr Asp Pro Ala His His Asp Ile Ser Ser His His
2075 2080 2085
Leu Ser Leu Asn Lys Val Arg His Asp Leu Ser Thr Leu Ser Glu
2090 2095 2100
Arg Asp Ile Gly Ser Leu Lys Tyr Ala Leu Ser Ser Leu Gln Ala
2105 2110 2115
Asp Thr Ser Ala Asp Gly Phe Ala Ala Ile Ala Ser Phe His Gly
2120 2125 2130
Leu Pro Ala Lys Cys Asn Asp Ser His Asn Asn Glu Val Ala Cys
2135 2140 2145
Cys Ile His Gly Met Pro Thr Phe Pro His Trp His Arg Leu Tyr
2150 2155 2160
Thr Leu Gln Phe Glu Gln Ala Leu Arg Arg His Gly Ser Ser Val
2165 2170 2175
Ala Val Pro Tyr Trp Asp Trp Thr Lys Pro Ile His Asn Ile Pro
2180 2185 2190
His Leu Phe Thr Asp Lys Glu Tyr Tyr Asp Val Trp Arg Asn Lys
2195 2200 2205
Val Met Pro Asn Pro Phe Ala Arg Gly Tyr Val Pro Ser His Asp
2210 2215 2220
Thr Tyr Thr Val Arg Asp Val Gln Glu Gly Leu Phe His Leu Thr
2225 2230 2235
Ser Thr Gly Glu His Ser Ala Leu Leu Asn Gln Ala Leu Leu Ala
2240 2245 2250
Leu Glu Gln His Asp Tyr Cys Asp Phe Ala Val Gln Phe Glu Val
2255 2260 2265
Met His Asn Thr Ile His Tyr Leu Val Gly Gly Pro Gln Val Tyr
2270 2275 2280
Ser Leu Ser Ser Leu His Tyr Ala Ser Tyr Asp Pro Ile Phe Phe
2285 2290 2295
Ile His His Ser Phe Val Asp Lys Val Trp Ala Val Trp Gln Ala
2300 2305 2310
Leu Gln Glu Lys Arg Gly Leu Pro Ser Asp Arg Ala Asp Cys Ala
2315 2320 2325
Val Ser Leu Met Thr Gln Asn Met Arg Pro Phe His Tyr Glu Ile
2330 2335 2340
Asn His Asn Gln Phe Thr Lys Lys His Ala Val Pro Asn Asp Val
2345 2350 2355
Phe Lys Tyr Glu Leu Leu Gly Tyr Arg Tyr Asp Asn Leu Glu Ile
2360 2365 2370
Gly Gly Met Asn Leu His Glu Ile Glu Lys Glu Ile Lys Asp Lys
2375 2380 2385
Gln His His Val Arg Val Phe Ala Gly Phe Leu Leu His Gly Ile
2390 2395 2400
Arg Thr Ser Ala Asp Val Gln Phe Gln Ile Cys Lys Thr Ser Glu
2405 2410 2415
Asp Cys His His Gly Gly Gln Ile Phe Val Leu Gly Gly Thr Lys
2420 2425 2430
Glu Met Ala Trp Ala Tyr Asn Arg Leu Phe Lys Tyr Asp Ile Thr
2435 2440 2445
His Ala Leu His Asp Ala His Ile Thr Pro Glu Asp Val Phe His
2450 2455 2460
Pro Ser Glu Pro Phe Phe Ile Lys Val Ser Val Thr Ala Val Asn
2465 2470 2475
Gly Thr Val Leu Pro Ala Ser Ile Leu His Ala Pro Thr Ile Ile
2480 2485 2490
Tyr Glu Pro Gly Leu Asp His His Glu Asp His His Ser Ser Ser
2495 2500 2505
Met Ala Gly His Gly Val Arg Lys Glu Ile Asn Thr Leu Thr Thr
2510 2515 2520
Ala Glu Val Asp Asn Leu Lys Asp Ala Met Arg Ala Val Met Ala
2525 2530 2535
Asp His Gly Pro Asn Gly Tyr Gln Ala Ile Ala Ala Phe His Gly
2540 2545 2550
Asn Pro Pro Met Cys Pro Met Pro Asp Gly Lys Asn Tyr Ser Cys
2555 2560 2565
Cys Thr His Gly Met Ala Thr Phe Pro His Trp His Arg Leu Tyr
2570 2575 2580
Thr Lys Gln Met Glu Asp Ala Leu Thr Ala His Gly Ala Arg Val
2585 2590 2595
Gly Leu Pro Tyr Trp Asp Gly Thr Thr Ala Phe Thr Ala Leu Pro
2600 2605 2610
Thr Phe Val Thr Asp Glu Glu Asp Asn Pro Phe His His Gly His
2615 2620 2625
Ile Asp Tyr Leu Gly Val Asp Thr Thr Arg Ser Pro Arg Asp Lys
2630 2635 2640
Leu Phe Asn Asp Pro Glu Arg Gly Ser Glu Ser Phe Phe Tyr Arg
2645 2650 2655
Gln Val Leu Leu Ala Leu Glu Gln Thr Asp Phe Cys Gln Phe Glu
2660 2665 2670
Val Gln Phe Glu Ile Thr His Asn Ala Ile His Ser Trp Thr Gly
2675 2680 2685
Gly Leu Thr Pro Tyr Gly Met Ser Thr Leu Glu Tyr Thr Thr Tyr
2690 2695 2700
Asp Pro Leu Phe Trp Leu His His Ala Asn Thr Asp Arg Ile Trp
2705 2710 2715
Ala Ile Trp Gln Ala Leu Gln Glu Tyr Arg Gly Leu Pro Tyr Asp
2720 2725 2730
His Ala Asn Cys Glu Ile Gln Ala Met Lys Arg Pro Leu Arg Pro
2735 2740 2745
Phe Ser Asp Pro Ile Asn His Asn Ala Phe Thr His Ser Asn Ala
2750 2755 2760
Lys Pro Thr Asp Val Phe Glu Tyr Ser Arg Phe Asn Phe Gln Tyr
2765 2770 2775
Asp Asn Leu Arg Phe His Gly Met Thr Ile Lys Lys Leu Glu His
2780 2785 2790
Glu Leu Glu Lys Gln Lys Glu Glu Asp Arg Thr Phe Ala Ala Phe
2795 2800 2805
Leu Leu His Gly Ile Lys Lys Ser Ala Asp Val Ser Phe Asp Val
2810 2815 2820
Cys Asn His Asp Gly Glu Cys His Phe Ala Gly Thr Phe Ala Ile
2825 2830 2835
Leu Gly Gly Glu His Glu Met Pro Trp Ser Phe Asp Arg Leu Phe
2840 2845 2850
Arg Tyr Asp Ile Thr Gln Val Leu Lys Gln Met His Leu Glu Tyr
2855 2860 2865
Asp Ser Asp Phe Thr Phe His Met Arg Ile Ile Asp Thr Ser Gly
2870 2875 2880
Lys Gln Leu Pro Ser Asp Leu Ile Lys Met Pro Thr Val Glu His
2885 2890 2895
Ser Pro Gly Gly Lys His His Glu Lys His His Glu Asp His His
2900 2905 2910
Glu Asp Ile Leu Val Arg Lys Asn Ile His Ser Leu Ser His His
2915 2920 2925
Glu Ala Glu Glu Leu Arg Asp Ala Leu Tyr Lys Leu Gln Asn Asp
2930 2935 2940
Glu Ser His Gly Gly Tyr Glu His Ile Ala Gly Phe His Gly Tyr
2945 2950 2955
Pro Asn Leu Cys Pro Glu Lys Gly Asp Glu Lys Tyr Pro Cys Cys
2960 2965 2970
Val His Gly Met Ser Ile Phe Pro His Trp His Arg Leu His Thr
2975 2980 2985
Ile Gln Phe Glu Arg Ala Leu Lys Lys His Gly Ser His Leu Gly
2990 2995 3000
Ile Pro Tyr Trp Asp Trp Thr Gln Thr Ile Ser Ser Leu Pro Thr
3005 3010 3015
Phe Phe Ala Asp Ser Gly Asn Asn Asn Pro Phe Phe Lys Tyr His
3020 3025 3030
Ile Arg Ser Ile Asn Gln Asp Thr Val Arg Asp Val Asn Glu Ala
3035 3040 3045
Ile Phe Gln Gln Thr Lys Phe Gly Glu Phe Ser Ser Ile Phe Tyr
3050 3055 3060
Leu Ala Leu Gln Ala Leu Glu Glu Asp Asn Tyr Cys Asp Phe Glu
3065 3070 3075
Val Gln Tyr Glu Ile Leu His Asn Glu Val His Ala Leu Ile Gly
3080 3085 3090
Gly Ala Glu Lys Tyr Ser Met Ser Thr Leu Glu Tyr Ser Ala Phe
3095 3100 3105
Asp Pro Tyr Phe Met Ile His His Ala Ser Leu Asp Lys Ile Trp
3110 3115 3120
Ile Ile Trp Gln Glu Leu Gln Lys Arg Arg Val Lys Pro Ala His
3125 3130 3135
Ala Gly Ser Cys Ala Gly Asp Ile Met His Val Pro Leu His Pro
3140 3145 3150
Phe Asn Tyr Glu Ser Val Asn Asn Asp Asp Phe Thr Arg Glu Asn
3155 3160 3165
Ser Leu Pro Asn Ala Val Val Asp Ser His Arg Phe Asn Tyr Lys
3170 3175 3180
Tyr Asp Asn Leu Asn Leu His Gly His Asn Ile Glu Glu Leu Glu
3185 3190 3195
Glu Val Leu Arg Ser Leu Arg Leu Lys Ser Arg Val Phe Ala Gly
3200 3205 3210
Phe Val Leu Ser Gly Ile Arg Thr Thr Ala Val Val Lys Val Tyr
3215 3220 3225
Ile Lys Ser Gly Thr Asp Ser Asp Asp Glu Tyr Ala Gly Ser Phe
3230 3235 3240
Val Ile Leu Gly Gly Ala Lys Glu Met Pro Trp Ala Tyr Glu Arg
3245 3250 3255
Leu Tyr Arg Phe Asp Ile Thr Glu Thr Val His Asn Leu Asn Leu
3260 3265 3270
Thr Asp Asp His Val Lys Phe Arg Phe Asp Leu Lys Lys Tyr Asp
3275 3280 3285
His Thr Glu Leu Asp Ala Ser Val Leu Pro Ala Pro Ile Ile Val
3290 3295 3300
Arg Arg Pro Asn Asn Ala Val Phe Asp Ile Ile Glu Ile Pro Ile
3305 3310 3315
Gly Lys Asp Val Asn Leu Pro Pro Lys Val Val Val Lys Arg Gly
3320 3325 3330
Thr Lys Ile Met Phe Met Ser Val Asp Glu Ala Val Thr Thr Pro
3335 3340 3345
Met Leu Asn Leu Gly Ser Tyr Thr Ala Met Phe Lys Cys Lys Val
3350 3355 3360
Pro Pro Phe Ser Phe His Ala Phe Glu Leu Gly Lys Met Tyr Ser
3365 3370 3375
Val Glu Ser Gly Asp Tyr Phe Met Thr Ala Ser Thr Thr Glu Leu
3380 3385 3390
Cys Asn Asp Asn Asn Leu Arg Ile His Val His Val Asp Asp Glu
3395 3400 3405
<210> 2
<211> 10227
<212> DNA
<213> 钥孔血蓝蛋白(KLH,keyhole limpet hemocyanin)
<400> 2
atgctgtcgg tcaggttgct tatagtcgtg ttggctttgg ccaatgcaga gaacctggtc 60
agaaagagtg tggagcatct gactcaggaa gagaccctgg acctgcaggc tgccctgcgt 120
gagctgcaga tggactcatc cagcattggt ttccagaaaa tagctgctgc tcatggcgcg 180
cccgcatctt gtgtgcataa ggacacttct atagcttgct gtattcacgg catgcctact 240
ttcccgcact ggcacagggc gtacgtagtt cacatggagc gagctctgca gacgaagagg 300
cgtacttctg gcctgcctta ctgggactgg acagaaccca tcacccagtt gccctctctc 360
gctgcggacc ctgtttacat cgattcccag ggcggaaagg ctcacaccaa ctactggtac 420
agagggaaca ttgactttct agacaagaaa accaatcgtg cggtcgacga ccgtcttttt 480
gagaaagtga agccaggcca gcacacccat cttatggaga gtgttttgga cgcactggag 540
caggatgaat tctgtaaatt cgaaatccag ttcgagttag cacataatgc gattcactac 600
ctggtcggtg gaaagcatga ttactctatg gcaaacctcg agtacaccgc ctacgatccg 660
atcttctttc ttcaccactc caacgttgac agaattttcg ccatctggca gaggctccaa 720
gagctccgaa acaaagaccc caaagctatg gattgtgccc aagaattgtt acatcagaaa 780
atggaacctt tcagttggga ggacaatgac ataccactaa caaatgacta tgacacgttg 840
aatcttaatg gtatgactcc agaggaactg aaaacctatt tggatgagcg gtcttcaagg 900
gcaagagcct tcgcaagctt ccgtctgaaa ggatttggag gttcagccaa tgtctttgtg 960
tacgtctgca tccccgacga caacgatcgt aatgatgacc actgtgagaa ggccggtgat 1020
ttcttcgttc tgggcggacc aagcgagatg aaatggcagt tctacaggcc atacttgttt 1080
gacttgtccg acactgttca caagatggga atgaagttgg atggacacta taccgtcaag 1140
gcagagcttt tcagtgtcaa tggtacagct cttcccgatg atttgttacc tcatccagtt 1200
gttgttcatc atccggagaa gggtttcact gatcctccgg tgaagcatca ccaaagcgcc 1260
aatctcctcg ttagaaagaa catcaatgat ctcacccgtg aagaagtgtt gaatctgaga 1320
gaggcgtttc ataaattcca agaagatcgc tccgtcgacg gttatcaagc cacagctgag 1380
tatcatggtc ttccggccag atgccctcgc cctgatgcca aggacagata tgcttgttgt 1440
gtccatggaa tgccaatctt ccctcactgg cacaggcttt ttgtcacaca agttgaagat 1500
gctttagtag gccgtggagc taccattggt atcccgtact ggggcctacc gtactgggac 1560
tggactgaac ccatgacaca cattccgggt ctggcaggaa acaaaactta tgtggattct 1620
catggtgcat cccacacaaa tccttttcat agttcagtga ttgcatttga agaaaatgct 1680
ccccacacca aaagacaaat agatcaaaga ctctttaaac ccgctacctt tggacaccac 1740
acagacctgt tcaaccagat tttgtatgcc tttgaacaag aagattactg tgactttgaa 1800
gtccaatttg agattaccca taacacgatt cacgcttgga caggaggaag cgaacatttc 1860
tcaatgtcgt ccctacatta cacagctttc gatcctttgt tttactttca ccattctaac 1920
gttgatcgtc tttgggccgt ttggcaagcc ttacagatga gacggcataa accctacagg 1980
gcccactgcg ccatatctct ggaacatatg catctgaaac cattcgcctt ttcatctccc 2040
cttaacaata acgaaaagac tcatgccaat gccatgccaa acaagatcta cgactatgaa 2100
aatgtcctcc attacacata cgaagattta acatttggag gcatctctct ggaaaacata 2160
gaaaagatga tccacgaaaa ccagcaagaa gacagaatat atgccggttt tctcctggct 2220
ggcatacgta cttcagcaaa tgttgatatc ttcattaaaa ctaccgattc cgtgcaacat 2280
aaggctggaa catttgcagt gctcggtgga agcaaggaaa tgaagtgggg atttgatcgc 2340
gttttcaagt ttgacatcac gcacgttttg aaagatctcg atctcactgc tgatggcgat 2400
ttcgaagtta ctgttgacat cactgaagtc gatggaacta aacttgcatc cagtcttatt 2460
ccacatgctt ctgtcattcg tgagcatgca cgtggtaagc tgaatagagt taaatttgac 2520
aaagtgccaa ggagtcgtct tattcgaaaa aatgtagacc gtttgagccc cgaggagatg 2580
aatgaacttc gtaaagccct agccttactg aaagaggaca aaagtgccgg tggatttcag 2640
cagcttggtg cattccatgg ggagccaaaa tggtgtccta gtcccgaagc atctaaaaaa 2700
tttgcctgct gtgttcacgg catgtctgtg ttccctcact ggcatcgact gttgacggtt 2760
cagagtgaaa atgctttgag acgacatggc tacgatggag ctttgccgta ctgggattgg 2820
acctctcctc ttaatcacct tcccgaactg gcagatcatg agaagtacgt cgaccctgaa 2880
gatggggtag agaagcataa cccttggttc gatggtcata tagatacagt cgacaaaaca 2940
acaacaagaa gtgttcagaa taaactcttc gaacagcctg agtttggtca ttatacaagc 3000
attgccaaac aagtactgct agcgttggaa caggacaatt tctgtgactt tgaaatccaa 3060
tatgagattg cccataacta catccatgca cttgtaggag gcgctcagcc ttatggtatg 3120
gcatcgcttc gctacactgc ttttgatcca ctattctact tgcatcactc taatacagat 3180
cgtatatggg caatatggca ggctttacag aagtacagag gaaaaccgta caacgttgct 3240
aactgtgctg ttacatcgat gagagaacct ttgcaaccat ttggcctctc tgccaatatc 3300
aacacagacc atgtaaccaa ggagcattca gtgccattca acgtttttga ttacaagacc 3360
aatttcaatt atgaatatga cactttggaa tttaacggtc tctcaatctc tcagttgaat 3420
aaaaagctcg aagcgataaa gagccaagac aggttctttg caggcttcct gttatctggt 3480
ttcaagaaat catctcttgt taaattcaat atttgcaccg atagcagcaa ctgtcacccc 3540
gctggagagt tttaccttct gggtgatgaa aacgagatgc catgggcata cgatagagtc 3600
ttcaaatatg acataaccga aaaactccac gatctaaagc tgcatgcaga agaccacttc 3660
tacattgact atgaagtatt tgaccttaaa ccagcaagcc tgggaaaaga tttgttcaag 3720
cagccttcag tcattcatga accaagaata ggtcaccatg aaggcgaagt atatcaagct 3780
gaagtaactt ctgccaaccg tattcgaaaa aacattgaaa atctgagcct tggtgaactc 3840
gaaagtctga gagctgcctt cctggaaatt gaaaacgatg gaacttacga atcaatagct 3900
aaattccatg gtagccctgg tttgtgccag ttaaatggta accccatctc ttgttgtgtc 3960
catggcatgc caactttccc tcactggcac agactgtacg tggttgtcgt tgagaatgcc 4020
ctcctgaaaa aaggatcatc tgtagctgtt ccctattggg actggacaaa acgaatcgaa 4080
catttacctc acctgatttc agacgccact tactacaatt ccaggcaaca tcactatgag 4140
acaaacccat tccatcatgg caaaatcaca cacgagaatg aaatcactac tagggatccc 4200
aaggacagcc tcttccattc agactacttt tacgagcagg tcctttacgc cttggagcag 4260
gataacttct gtgatttcga gattcagttg gagatattac acaatgcatt gcattcttta 4320
cttggtggca aaggtaaata ttccatgtca aaccttgatt acgctgcttt tgatcctgtg 4380
ttcttccttc atcacgcaac gactgacaga atctgggcaa tctggcaaga ccttcagagg 4440
ttccgaaaac ggccataccg agaagcgaat tgcgctatcc aattgatgca cacgccactc 4500
cagccgtttg ataagagcga caacaatgac gaggcaacga aaacgcatgc cactccacat 4560
gatggttttg aatatcaaaa cagctttggt tatgcttacg ataatctgga actgaatcac 4620
tactcgattc ctcagcttga tcacatgctg caagaaagaa aaaggcatga cagagtattc 4680
gctggcttcc tccttcacaa tattggaaca tctgccgatg gccatgtatt tgtatgtctc 4740
ccaactgggg aacacacgaa ggactgcagt catgaggctg gtatgttctc catcttaggc 4800
ggtcaaacgg agatgtcctt tgtatttgac agactttaca aacttgacat aactaaagcc 4860
ttgaaaaaga acggtgtgca cctgcaaggg gatttcgatc tggaaattga gattacggct 4920
gtgaatggat ctcatctaga cagtcatgtc atccactctc ccactatact gtttgaggcc 4980
ggaacagatt ctgcccacac agatgatgga cacactgaac cagtgatgat tcgcaaagat 5040
atcacacaat tggacaagcg tcaacaactg tcactggtga aagccctcga gtccatgaaa 5100
gccgaccatt catctgatgg gttccaggca atcgcttcct tccatgctct tcctcctctt 5160
tgtccatcac cagctgcttc aaagaggttt gcgtgctgcg tccatggcat ggcaacgttc 5220
ccacaatggc accgtctgta cacagtccaa ttccaagatt ctctcagaaa acatggtgca 5280
gtcgttggac ttccgtactg ggactggacc ctacctcgtt ctgaattacc agagctcctg 5340
accgtctcaa ctattcatga cccggagaca ggcagagata taccaaatcc atttattggt 5400
tctaaaatag agtttgaagg agaaaacgta catactaaaa gagatatcaa tagggatcgt 5460
ctcttccagg gatcaacaaa aacacatcat aactggttta ttgagcaagc actgcttgct 5520
cttgaacaaa ccaactactg cgacttcgag gttcagtttg aaattatgca taatggtgtt 5580
catacctggg ttggaggcaa ggagccctat ggaattggcc atctgcatta tgcttcctat 5640
gatccacttt tctacatcca tcactcccaa actgatcgta tttgggctat atggcaatcg 5700
ttgcagcgtt tcagaggact ttctggatct gaggctaact gtgctgtaaa tctcatgaaa 5760
actcctctga agcctttcag ctttggagca ccatataatc ttaatgatca cacgcatgat 5820
ttctcaaagc ctgaagatac attcgactac caaaagtttg gatacatata tgacactctg 5880
gaatttgcag ggtggtcaat tcgtggcatt gaccatattg tccgtaacag gcaggaacat 5940
tcaagggtct ttgccggatt cttgcttgaa ggatttggca cctctgccac tgtcgatttc 6000
caggtctgtc gcacagcggg agactgtgaa gatgcagggt acttcaccgt gttgggaggt 6060
gaaaaagaaa tgccttgggc ctttgatcgg ctttacaagt acgacataac agaaacctta 6120
gacaagatga accttcgaca tgacgaaatc ttccagattg aagtaaccat tacatcctac 6180
gatggaactg tactcgatag tggccttatt cccacaccgt caatcatcta tgatcctgct 6240
catcatgata ttagttcgca ccacctgtcg ctcaacaagg ttcgtcatga tctgagtaca 6300
ctgagtgagc gagatattgg aagccttaaa tatgctttga gcagcttgca ggcagatacc 6360
tcagcagatg gttttgctgc cattgcatcc ttccatggtc tgcctgccaa atgtaatgac 6420
agccacaata acgaggtggc atgctgtatc catggaatgc ctacattccc ccactggcac 6480
agactctaca ccctccaatt tgagcaagct ctaagaagac atggctctag tgtagcagta 6540
ccctactggg actggacaaa gccaatacat aatattccac atctgttcac agacaaagaa 6600
tactacgatg tctggagaaa taaagtaatg ccaaatccat ttgcccgagg gtatgtcccc 6660
tcacacgata catacacggt aagagacgtc caagaaggcc tgttccacct gacatcaacg 6720
ggtgaacact cagcgcttct gaatcaagct cttttggcgc tggaacagca cgactactgc 6780
gattttgcag tccagtttga agtcatgcac aacacaatcc attacctagt gggaggacct 6840
caagtctatt ctttgtcatc ccttcattat gcttcatatg atccgatctt cttcatacac 6900
cactcctttg tagacaaggt ttgggctgtc tggcaggctc ttcaagaaaa gagaggcctt 6960
ccatcagacc gtgctgactg cgctgttagt ctgatgactc agaacatgag gcctttccat 7020
tacgaaatta accataacca gttcaccaag aaacatgcag ttccaaatga tgttttcaag 7080
tacgaactcc tgggttacag atacgacaat ctggaaatcg gtggcatgaa tttgcatgaa 7140
attgaaaagg aaatcaaaga caaacagcac catgtgagag tgtttgcagg gttcctcctt 7200
cacggaatta gaacctcagc tgatgtccaa ttccagattt gtaaaacatc agaagattgt 7260
caccatggag gccaaatctt cgttcttggg gggactaaag agatggcctg ggcttataac 7320
cgtttattca agtacgatat tacccatgct cttcatgacg cacacatcac tccagaagac 7380
gtattccatc cctctgaacc attcttcatc aaggtgtcag tgacagccgt caacggaaca 7440
gttcttccgg cttcaatcct gcatgcacca accattatct atgaacctgg tctcgaccat 7500
cacgaagatc atcattcttc ttctatggct ggacatggtg tcagaaagga aatcaacaca 7560
cttaccactg cagaggtgga caatctcaaa gatgccatga gagccgtcat ggcagaccac 7620
ggtccaaatg gataccaggc tatagcagcg ttccatggaa acccaccaat gtgccctatg 7680
ccagatggaa agaattactc gtgttgtaca catggcatgg ctactttccc ccactggcac 7740
agactgtaca caaaacagat ggaagatgcc ttgaccgccc atggtgccag agtcggcctt 7800
ccttactggg acgggacaac tgcctttaca gctttgccaa cttttgtcac agatgaagag 7860
gacaatcctt tccatcatgg tcacatagac tatttgggag tggatacaac tcggtcgccc 7920
cgagacaagt tgttcaatga tccagagcga ggatcagaat cgttcttcta caggcaggtt 7980
ctcttggctt tggagcagac agatttttgt cagtttgaag tccagttcga gattacccac 8040
aatgccatcc attcttggac tggtggactg accccctacg gaatgtccac tctggagtac 8100
acgacctatg atcctctttt ctggcttcat catgccaata ctgaccgaat atgggctatt 8160
tggcaagctc ttcaagaata cagaggtctc ccatacgacc atgccaactg cgaaatccag 8220
gcaatgaaga ggcccctacg gccattctct gatcctatta atcacaatgc gttcactcat 8280
tctaacgcaa aaccaacaga cgttttcgag tacagtagat tcaacttcca gtatgataac 8340
ttacggtttc atggtatgac aataaaaaag ttggagcatg agcttgagaa acagaaggaa 8400
gaagacagga cattcgctgc cttcctgctc cacggcatta aaaaaagtgc tgatgtaagc 8460
tttgacgtgt gcaaccatga tggagaatgc cactttgcag gtaccttcgc tattcttgga 8520
ggcgagcacg agatgccttg gtcctttgac agacttttcc gatatgacat cacccaagtt 8580
cttaagcaaa tgcacctgga gtatgattct gatttcacgt tccatatgag aattattgac 8640
acttcgggta aacaactgcc atcagacctg atcaagatgc caacggttga acacagccca 8700
ggaggaaaac atcatgagaa acatcatgaa gatcaccatg aagacatact tgttcgtaaa 8760
aacattcact ctctgtcaca ccatgaagcc gaagaattga gagatgcatt gtacaagctt 8820
caaaacgatg aaagtcacgg tggatatgaa catattgctg gattccatgg ttatcctaac 8880
ctctgtcctg aaaaagggga tgaaaagtat ccttgctgtg ttcatggtat gtctatattc 8940
ccccactggc acaggctcca cacgatacag tttgaaagag ctctgaagaa acatggttcc 9000
catctcggta ttccttactg ggattggact cagacgatat cgtctcttcc taccttcttt 9060
gcagattctg gtaataataa tccattcttc aaataccata tcagaagcat aaatcaagac 9120
actgttcgag acgttaatga agcgatattc caacaaacga agtttggaga attttcgtcc 9180
atattttacc tggccttgca ggctctagaa gaggacaatt attgcgattt tgaggtgcag 9240
tacgagatac ttcacaatga ggtgcatgcc ttgattggtg gagccgagaa gtattccatg 9300
tccacgctgg aatattcagc cttcgatcca tacttcatga tccaccacgc gtctttggac 9360
aagatctgga taatctggca ggagcttcag aaacgccggg ttaagcctgc acatgctggt 9420
tcgtgtgccg gagacattat gcacgttcca cttcatcctt tcaattatga aagcgtcaac 9480
aacgatgact ttaccagaga gaattctctc cccaacgcgg tcgttgacag tcatagattc 9540
aactataaat atgacaatct taatcttcac ggccacaata tagaggagct tgaggaggtt 9600
ctccgcagcc tgagacttaa atctcgtgtt ttcgcaggat ttgttctgtc cggaatccgc 9660
acaactgcag ttgtgaaagt gtatatcaaa agcggaaccg attccgacga cgaatatgcc 9720
ggttcgtttg tcatccttgg aggagccaaa gagatgcctt gggcatatga gaggttgtat 9780
agatttgaca ttacagaaac tgtacacaat cttaacctta cggatgatca tgttaaattc 9840
aggtttgact taaagaaata tgatcatact gaattggatg catcagtact gccagctcct 9900
ataatcgttc gacgtccaaa taatgcggtt tttgatatca ttgagattcc aatagggaaa 9960
gacgtgaatc ttccaccgaa ggtggtcgtc aagagaggca ctaaaatcat gttcatgtct 10020
gttgatgaag ccgttaccac tcccatgctg aacctgggta gttatacagc aatgttcaaa 10080
tgtaaagtgc caccattcag cttccatgct tttgagcttg ggaaaatgta ttctgtcgaa 10140
tctggtgact atttcatgac ggcatcaaca actgaattat gcaacgataa taacttaagg 10200
atacatgtcc atgtggatga cgaatag 10227
<210> 3
<211> 743
<212> DNA
<213> 人工序列
<400> 3
ccatggtttc agtgcgcctg ttgattgtcg tgttggcttt agctaatgca gagaatttgg 60
ttcgcaagtc agttgaacac ttgactcaag aggagactct tgatttacaa gcagcacttc 120
gtgaattgca aatggattcg agatccattg ggtttcagaa aattgcggct gcccacgggg 180
ccccagcttc atgtgtccat aaggatactt cgattgcgtg ttgtatccac ggcatgccta 240
catttccgca ctggcatcgt gcctacgttg ttcatatgga gcgcgccttg cagacaaagc 300
gtcgcacaag cgggcttccg tattgggatt ggacagaacc aattactcaa ttaccaagtc 360
tggcagcgga ccctgtgtat attgattcac agggaggcaa ggcccataca aattactggt 420
atcgcggcaa cattgatttc cttgacaaga aaaccaaccg cgcagttgat gatcgtcttt 480
ttgagaaggt gaagccagga cagcatactc acctgatgga gtcggtattg gacgctcttg 540
aacaagacga gttctgcaaa ttcgaaattc agttcgagct tgcccataac gctattcatt 600
acttggtcgg ggggaaacat gattattcta tggccaacct tgagtacaca gcgtatgacc 660
ctatcttttt tttgcatcat tccaatgtag atcgtatttt tgcgatctgg cagcgtttgc 720
aagagcttcg caacaaagga tcc 743
<210> 4
<211> 1488
<212> DNA
<213> 人工序列
<400> 4
atgttagaac atttctgtga atgctattct aatctaagtg gtcttattct gtgtcctgtg 60
ctaggaagca ttactcttct tttcattcca aattcaagaa tacgaccgat acgattaatt 120
ggtctgtgtg cctctcttat tacttttttg tattctcctg ttcctcggat acaattcgac 180
tcttctacgg ccaaatctca atttgtggaa agccttcgat ggcttcctta tgaaaacatc 240
aatttttatt tgggtataga cggtatctct ttattcttcg tgatattgac cacatttctg 300
atccctattt gcatttcagt gggttggtct ggtatgagaa gttatgggaa agagtatatt 360
acagcatttt taattcgtga atttctaatg atcgccgtgt tccgcatgct agatcttcta 420
ctattctatg tttttcccga aagcgtgcca atccctatgt tcattattat aggagtatgg 480
ggttcgagac aaagaaagat caaggcagca tatcagtttt tcctttatac tttacttgga 540
tctcttttta tgctattagc tattctgttg attcttttcc aaacaggaac caccgattta 600
caaatatcat taaccacaga atttagtgag cggcgccaaa tctttctatg gattgcttct 660
ttcgcctctt tcgccgtcaa agtgcctatg gtaccagttc atatttggtt acctgaagct 720
catgtagagg cacctacggc aggatccgtc atcttggcag gaattccttt aaaatttgga 780
acccacgggt ttttaagatt ttcaataccc atgtttcccg aagcgacact ttgttctact 840
cctttcattt atactttaag cgcgattgct ataatatata cttccttgac cacttcaaga 900
cagatcgatc taaagaagat cattgcttac tcctcagtag cccatatgaa tctggtgact 960
attggtatgt ttagtccgaa catacaggga attggaggta gcattctacc gatgttaagt 1020
catggactgg ttccttcagc cctttttcta tgtgttggtg ttttatatga ccgacataag 1080
actcgacttg ttagatatta cggaggttta gtgagcacca tgccgaatct ctctaccatt 1140
ttcttttctt ttactttggc caatatgagt tcacctggta ctagcagctt tatcggggaa 1200
tttctcatct tagtaggagc tttccaaaga aatagcttag tagccacatt agcagcgctt 1260
gggatgattt taggtgcggc ctattccctt tggctatata atcgtgtggt ttctggaaat 1320
ttaaaacctg atttcctcca taaattctcc gattcaaatg gcagagaagt ttccatattt 1380
ataccttttc ttgttggact cgttcggatg ggtgttcacc ccaaagtgtt cccggactgc 1440
atgcatacat ccgtaagtaa cttagtgcaa catggcaaat ttcattga 1488
<210> 5
<211> 495
<212> PRT
<213> 人工序列
<400> 5
Met Leu Glu His Phe Cys Glu Cys Tyr Ser Asn Leu Ser Gly Leu Ile
1 5 10 15
Leu Cys Pro Val Leu Gly Ser Ile Thr Leu Leu Phe Ile Pro Asn Ser
20 25 30
Arg Ile Arg Pro Ile Arg Leu Ile Gly Leu Cys Ala Ser Leu Ile Thr
35 40 45
Phe Leu Tyr Ser Pro Val Pro Arg Ile Gln Phe Asp Ser Ser Thr Ala
50 55 60
Lys Ser Gln Phe Val Glu Ser Leu Arg Trp Leu Pro Tyr Glu Asn Ile
65 70 75 80
Asn Phe Tyr Leu Gly Ile Asp Gly Ile Ser Leu Phe Phe Val Ile Leu
85 90 95
Thr Thr Phe Leu Ile Pro Ile Cys Ile Ser Val Gly Trp Ser Gly Met
100 105 110
Arg Ser Tyr Gly Lys Glu Tyr Ile Thr Ala Phe Leu Ile Arg Glu Phe
115 120 125
Leu Met Ile Ala Val Phe Arg Met Leu Asp Leu Leu Leu Phe Tyr Val
130 135 140
Phe Pro Glu Ser Val Pro Ile Pro Met Phe Ile Ile Ile Gly Val Trp
145 150 155 160
Gly Ser Arg Gln Arg Lys Ile Lys Ala Ala Tyr Gln Phe Phe Leu Tyr
165 170 175
Thr Leu Leu Gly Ser Leu Phe Met Leu Leu Ala Ile Leu Leu Ile Leu
180 185 190
Phe Gln Thr Gly Thr Thr Asp Leu Gln Ile Ser Leu Thr Thr Glu Phe
195 200 205
Ser Glu Arg Arg Gln Ile Phe Leu Trp Ile Ala Ser Phe Ala Ser Phe
210 215 220
Ala Val Lys Val Pro Met Val Pro Val His Ile Trp Leu Pro Glu Ala
225 230 235 240
His Val Glu Ala Pro Thr Ala Gly Ser Val Ile Leu Ala Gly Ile Pro
245 250 255
Leu Lys Phe Gly Thr His Gly Phe Leu Arg Phe Ser Ile Pro Met Phe
260 265 270
Pro Glu Ala Thr Leu Cys Ser Thr Pro Phe Ile Tyr Thr Leu Ser Ala
275 280 285
Ile Ala Ile Ile Tyr Thr Ser Leu Thr Thr Ser Arg Gln Ile Asp Leu
290 295 300
Lys Lys Ile Ile Ala Tyr Ser Ser Val Ala His Met Asn Leu Val Thr
305 310 315 320
Ile Gly Met Phe Ser Pro Asn Ile Gln Gly Ile Gly Gly Ser Ile Leu
325 330 335
Pro Met Leu Ser His Gly Leu Val Pro Ser Ala Leu Phe Leu Cys Val
340 345 350
Gly Val Leu Tyr Asp Arg His Lys Thr Arg Leu Val Arg Tyr Tyr Gly
355 360 365
Gly Leu Val Ser Thr Met Pro Asn Leu Ser Thr Ile Phe Phe Ser Phe
370 375 380
Thr Leu Ala Asn Met Ser Ser Pro Gly Thr Ser Ser Phe Ile Gly Glu
385 390 395 400
Phe Leu Ile Leu Val Gly Ala Phe Gln Arg Asn Ser Leu Val Ala Thr
405 410 415
Leu Ala Ala Leu Gly Met Ile Leu Gly Ala Ala Tyr Ser Leu Trp Leu
420 425 430
Tyr Asn Arg Val Val Ser Gly Asn Leu Lys Pro Asp Phe Leu His Lys
435 440 445
Phe Ser Asp Ser Asn Gly Arg Glu Val Ser Ile Phe Ile Pro Phe Leu
450 455 460
Val Gly Leu Val Arg Met Gly Val His Pro Lys Val Phe Pro Asp Cys
465 470 475 480
Met His Thr Ser Val Ser Asn Leu Val Gln His Gly Lys Phe His
485 490 495
<210> 6
<211> 25
<212> DNA
<213> 人工序列
<400> 6
tccgaattcg gtgttttata tgacc 25
<210> 7
<211> 26
<212> DNA
<213> 人工序列
<400> 7
gcaagcttat gaaatttgcc atgttg 26

Claims (10)

1.一种融合蛋白,其特征在于,包含钥孔血蓝蛋白片段及目的蛋白。
2.根据权利要求1所述的融合蛋白,其特征在于,所述的钥孔血蓝蛋白片段包含钥孔血蓝蛋白第1-245位氨基酸残基。
3.根据权利要求1所述的融合蛋白,其特征在于,所述的钥孔血蓝蛋白片段包含SEQ IDNO:1所示的第1-245位氨基酸残基。
4.根据权利要求1所述的融合蛋白,其特征在于,所述的目的蛋白为植物线粒体膜蛋白或其免疫原性片段。
5.根据权利要求1所述的融合蛋白,其特征在于,所述的目的蛋白的序列如SEQ ID NO:5所示。
6.根据权利要求1所述的融合蛋白,其特征在于,所述的钥孔血蓝蛋白片段连接至所述目的蛋白的N端和/或C端。
7.编码权利要求1~6任一项所述的融合蛋白的核苷酸。
8.根据权利要求7所述的核苷酸,其特征在于,包含SEQ ID NO:3所述的核苷酸序列。
9.权利要求1~6任一项所述的融合蛋白在制备针对特异性目的蛋白多克隆抗体中的应用。
10.权利要求1~6任一项所述的融合蛋白在作为疫苗或药物的应用。
CN201710183230.XA 2017-03-24 2017-03-24 一种包含钥孔血蓝蛋白片段的融合蛋白及其应用 Active CN107056950B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710183230.XA CN107056950B (zh) 2017-03-24 2017-03-24 一种包含钥孔血蓝蛋白片段的融合蛋白及其应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710183230.XA CN107056950B (zh) 2017-03-24 2017-03-24 一种包含钥孔血蓝蛋白片段的融合蛋白及其应用

Publications (2)

Publication Number Publication Date
CN107056950A true CN107056950A (zh) 2017-08-18
CN107056950B CN107056950B (zh) 2020-10-20

Family

ID=59621084

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710183230.XA Active CN107056950B (zh) 2017-03-24 2017-03-24 一种包含钥孔血蓝蛋白片段的融合蛋白及其应用

Country Status (1)

Country Link
CN (1) CN107056950B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114134129A (zh) * 2021-11-19 2022-03-04 上海生物芯片有限公司 一种线粒体定位多肽、定位系统及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102115492A (zh) * 2010-01-05 2011-07-06 中国农业科学院北京畜牧兽医研究所 血管内皮生长因子受体部分多肽及其应用
CN103333236A (zh) * 2013-04-11 2013-10-02 哈尔滨体育学院 一种优秀冰雪运动员血管紧张素转化酶部分多肽多克隆抗体制备方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102115492A (zh) * 2010-01-05 2011-07-06 中国农业科学院北京畜牧兽医研究所 血管内皮生长因子受体部分多肽及其应用
CN103333236A (zh) * 2013-04-11 2013-10-02 哈尔滨体育学院 一种优秀冰雪运动员血管紧张素转化酶部分多肽多克隆抗体制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BENTOLILA,S.等: "Accession NO.: EF488916.1,Arabidopsis thaliana ecotype Columbia NADH dehydrogenase subunit 4 mRNA, partial cds; mitochondrial", 《GENBANK》 *
LIEB,B.等: "Accession NO.: CAG28309.2,hemocyanin 1 [Megathura crenulata]", 《GENBANK》 *
TANAKA,Y.等: "Accession NO.: YP_006666006.1,NADH dehydrogenase subunit 4 (mitochondrion) [Raphanus sativus]", 《GENBANK》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114134129A (zh) * 2021-11-19 2022-03-04 上海生物芯片有限公司 一种线粒体定位多肽、定位系统及其应用
CN114134129B (zh) * 2021-11-19 2022-11-29 上海生物芯片有限公司 一种线粒体定位多肽、定位系统及其应用

Also Published As

Publication number Publication date
CN107056950B (zh) 2020-10-20

Similar Documents

Publication Publication Date Title
CN110616192B (zh) 一种抗人神经丝轻链(nefl)的单克隆抗体及其应用
CN111349617B (zh) 一种分泌抗Tau或pTau-181/231/396单克隆抗体杂交瘤细胞株及其应用
RU2006127314A (ru) Вакцина, стимулирующая рост, основанная на нейтрализующем эпитопе
CN105542014B (zh) Tp重组抗原及其制备方法和应用
CN111333709B (zh) 旋毛虫肌幼虫期丝氨酸蛋白酶抑制剂的b细胞表位多肽、杂交瘤细胞株、单克隆抗体及应用
CN110845608B (zh) 一种番茄环斑病毒单克隆抗体及其制备方法
Yong Jeong et al. Molecular cloning and the allergenic characterization of tropomyosin from Tyrophagus putrescentiae
CN110885370A (zh) 分泌番茄环斑病毒单克隆抗体的杂交瘤细胞株及其抗体和抗体制备方法
CN114276445A (zh) 轮状病毒重组蛋白特异性抗体、质粒载体及方法
CN108530534B (zh) Nav1.9的靶点多肽、与其结合的抗体及抗体片段和相关药物组合物
CN110904059B (zh) 花青素合成酶抗原表位肽及其抗体与应用
CN107056950A (zh) 一种包含钥孔血蓝蛋白片段的融合蛋白及其应用
CN113527474A (zh) 一种抗新冠病毒n蛋白的单克隆抗体及其应用
Rihs et al. Recombinant Hev b 1: large‐scale production and immunological characterization
KR101920961B1 (ko) 다중 진단 키트
Mendes et al. Effective Tityus serrulatus anti-venom produced using the Ts1 component
CN110662763B (zh) Nav1.9的靶点多肽、与其结合的抗体及抗体片段和相关药物组合物
CN111303276B (zh) 旋毛虫肠道期半胱氨酸蛋白酶抑制剂的b细胞表位多肽、杂交瘤细胞株、单克隆抗体、应用
CN113087788B (zh) 一种特异性识别小麦内源自噬相关蛋白8多克隆抗体的制备方法
CN113004386B (zh) 草鱼过敏性毒素C5a重组蛋白及其多克隆抗体
CN111187754B (zh) 一种杂交瘤细胞株及其产生的抗旋毛虫肠道期丝氨酸蛋白酶单克隆抗体与应用
CN105906716B (zh) 埃可病毒9型vp1蛋白特异性抗原表位及其融合蛋白的制备、应用
CN114262376A (zh) 长牡蛎四种胰岛素样肽多克隆抗体及其制备方法和应用
Kouguchi et al. Characterization of various recombinant antigens from Echinococcus multilocularis for use in the immunodiagnosis
Kishimoto et al. Identification of the pentapeptide constituting a dominant epitope common to all eukaryotic heat shock protein 90 molecular chaperones

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant